Cargando…

Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer

BACKGROUND: Long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) plays a positive role in the progression of human malignant tumors. However, the molecular mechanism of SNHG1 remains elusive in breast cancer. RESULTS: LncRNA SNHG1 was upregulated and had a positive relationship with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yujuan, Wan, Lin, Wang, Qin, Yin, Yanling, Liu, Jiena, Liu, Lei, Wu, Hao, Zhang, Lei, Zhang, Xin, Xu, Shouping, Pang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407068/
https://www.ncbi.nlm.nih.gov/pubmed/34465388
http://dx.doi.org/10.1186/s13578-021-00675-5
Descripción
Sumario:BACKGROUND: Long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) plays a positive role in the progression of human malignant tumors. However, the molecular mechanism of SNHG1 remains elusive in breast cancer. RESULTS: LncRNA SNHG1 was upregulated and had a positive relationship with poor prognosis according to bioinformatics analysis in pan-cancer including breast cancer. Silencing SNHG1 inhibited tumorigenesis in breast cancer both in vitro and in vivo. Mechanistically, SNHG1 functioned as a competing endogenous RNA (ceRNA) to promote TERT expression by sponging miR-18b-5p in breast cancer. miR-18b-5p acted as a tumor repressor in breast cancer. Moreover, the combination of SNHG1 knockdown and TERT inhibitor administration showed a synergistic inhibitory effect on breast cancer growth in vivo. Finally, E2F1 as a transcription factor, binding to SNHG1 promoter and enhanced SNHG1 transcription in breast cancer. CONCLUSIONS: Our results provide a comprehensive understanding of the oncogenic mechanism of lncRNA SNHG1 in breast cancer. Importantly, we identified a novel E2F1–SNHG1–miR-18b-5p–TERT axis, which may be a potential therapeutic target for breast cancer. Our results also provided a potential treatment for breast cancer when knockdown SNHG1 and TERT inhibitor administration simultaneously. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-021-00675-5.